Skip Navigation



Carcinogenesis Advance Access published online on March 7, 2007

Carcinogenesis, doi:10.1093/carcin/bgm040
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
28/7/1446    most recent
bgm040v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Winkelmann, I.
Right arrow Articles by Wenzel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winkelmann, I.
Right arrow Articles by Wenzel, U.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs-cycle enzymes

Isabel Winkelmann1, Daniela Diehl2, Doris Oesterle3, Hannelore Daniel1 and Uwe Wenzel4,*

1 Molecular Nutrition Unit, Department of Food and Nutrition, Technical University of Munich, Am Forum 5, D-85350 Freising, Germany
2 Institute of Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilian-University of Munich, Feodor-Lynen-Str. 25, D-81377 Munich, Germany
3 Institute of Toxicology, GSF-National Research Center for Environment and Health, Ingolstädter Landstrasse 1, D-85764 Neuherberg, Germany
4 Molecular Nutrition Research, Interdisciplinary Research Center, Justus-Liebig-University of Giessen, Heinrich-Buff-Ring 26-32, D-35392 Giessen, Germany

* Corresponding author: Uwe Wenzel, Interdisciplinary Research Center, Molecular Nutrition Research, Heinrich-Buff-Ring 26-32, D-35392 Giessen, Telephone: +49 641/99-39220, Telefax: +49 641/99-39229, e-mail: uwe.wenzel{at}ernaehrung.uni-giessen.de

Colorectal cancer is the second leading cause of cancer deaths worldwide with diet playing a prominent role in disease initiation and progression. Flavonoids are secondary plant compounds that are suggested as protective ingredients of a diet rich in fruits and vegetables. We here tested whether flavone, a flavonoid that proved to be an effective apoptosis-inducer in colon cancer cells in culture, can affect the development of aberrant crypt foci in C57BL/6J mice in vivo when preneoplastic lesions were induced by the carcinogen 1,2-dimethylhydrazine. Flavone applied at either a low dose (15 mg/kg body weight per day) or a high dose (400 mg/kg body weight per day) reduced the numbers of aberrant crypt foci significantly, independent of whether it was supplied simultaneously with the carcinogen (blocking group) or subsequent to the tumor induction phase (suppressing group). Proteome analysis performed in colonic tissue samples revealed that flavone-treatment increased the expression of a number of Krebs-cycle enzymes in the suppressing group and this was associated with reduced crypt multiplicity. It suggests that mitochondrial substrate oxidation is increased by flavone in colonic cells in vivo as already observed in HT-29 cells in vitro as the prime mechanism underlying tumor cell apoptosis induction by flavone.

In conclusion, flavone reduces the number of aberrant crypt foci in 1,2-dimethylhydrazine-treated mice at doses that can be achieved for flavonoids by a diet rich in fruits and vegetables. Moreover, reduction in crypt multiplicity by flavone is most likely due to the preservation of a normal oxidative metabolism.

Received November 23, 2006; revised February 5, 2007; accepted February 9, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.